HOME › DRUGS › INTERFERON BETA-1A
ACTIVE SUBSTANCE / INN

INTERFERON BETA-1A

Brand name(s): AVONEX, Avonex, Rebif, Biferonex, REBIF
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
AUTHORISED
BLA103628
Multiple Sclerosis
ACTIVE SUBSTANCE
Interferon Beta-1A
REGULATORS
FDA · EMA
SPONSORS / MAH
Merck Europe B.V. , BioPartners GmbH, BIOGEN
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
AVONEXBLA103628BIOGENPrescription
REBIFBLA103780SERONO INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AvonexBiogen Netherlands B.V. Authorised13/03/1997Multiple Sclerosis
RebifMerck Europe B.V. Authorised03/05/1998Multiple Sclerosis
BiferonexBioPartners GmbHApplication withdrawnMultiple Sclerosis

FULL INTELLIGENCE ON INTERFERON BETA-1A

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →